Search results
May 20, 2024 · Dana-Farber’s breast oncology clinical investigators partner with major cancer centers to run multi-center clinical trials in places with diverse populations to reach more people of color and of diverse backgrounds.
May 15, 2024 · Dana-Farber researchers push the boundaries of a revolutionary treatment for cancer. Unleashing Potential. How experts are exploring AI's potential roles in predicting and diagnosing cancer. Blocking the Connection. Investigators examine how new drugs called menin inhibitors can stop cancer progression
May 6, 2024 · Investigators at Dana-Farber Cancer Institute have examined the historical evolution of Community Outreach and Engagement initiatives at both the National Cancer Institute (NCI) and National Cancer Institute-Designated Cancer Centers (NCI-DCCs).
May 8, 2024 · A team of Dana-Farber Cancer Institute investigators discovered that a subset of myeloid and lymphoid leukemias depend on a molecular complex called PI3Kgamma for survival.
May 20, 2024 · Each of eFFECTOR’s product candidates is designed to act on a single protein that drives the expression of a network of functionally related proteins, including oncoproteins and immunosuppressive proteins in T cells, that together control tumor growth, survival, and immune evasion.
May 6, 2024 · Dana-Farber review article examines past and guides future efforts to reduce cancer disparities. BOSTON—Investigators at Dana-Farber Cancer Institute have examined the historical evolution of Community Outreach and Engagement initiatives at both the National Cancer Institute (NCI) and National Cancer Institute-Designated Cancer Centers (NCI ...
May 6, 2024 · BOSTON—Investigators at Dana-Farber Cancer Institute have examined the historical evolution of Community Outreach and Engagement initiatives at both the National Cancer Institute (NCI) and...
